Mintz advised the underwriters in connection with NervGen Pharma’s $60 million public offering of common shares and accompanying warrants.
Leerink Partners and TD Cowen acted as joint bookrunning managers for the offering.
The Mintz cross-border capital markets team included William Hicks, John Rudy, Eric Foster, Alok Choksi, Matthew Imrie, Sam Silver, Tully Cogswell, Jocelyn Sun, and Zach Irwin. Lee Johnson and Iris Cheung assisted with intellectual property matters, Benjamin Zegarelli assisted with regulatory matters, Ari Feder assisted with US tax matters and Katy Pitch assisted with Canadian tax matters. Members of the Mintz team are based in the Boston, New York, Toronto and San Diego offices.